Public Health · Research

Harm Reduction for People Who Use Drugs reports

Coverage across 7 countries and regions. Each report follows the same 16 sections, with sources and data gaps named.

Get the full Harm Reduction for People Who Use Drugs public health report

The full report covers burden, affected groups, risk factors, screening, treatment coverage, programmes, gaps and outlook, with a source and year for every figure.

Buy the full report Request free sample
Harm Reduction for People Who Use Drugs reports by place
PlaceActive trialsReport
World3View report
Afghanistan0View report
Egypt0View report
India0View report
Kenya0View report
Myanmar0View report
Pakistan0View report

Public clinical research

3 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Prescribing to protect case series: naltrexone as a novel intervention to prevent fentanyl overdose in people who use cocaine.Addiction science & clinical practice, 2026
  2. Same name, different drugs: variability of fentanyl ('dope') products sold under the same label.The International journal on drug policy, 2026
  3. Current Tobacco Product Use and Cessation Behaviors Among People Who Use Opioids: Implications for Integrated Harm Reduction Services.Tobacco use insights, 2026
  4. Moral injury and substance use among Veterans: Opportunities and challenges in rural areas.Journal of military, veteran and family health, 2025

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.